Neurogene (NGNE) Prepaid Assets (2013 - 2026)

Neurogene (NGNE) reported Prepaid Assets of $3.6 million for Q1 2026, up 257.57% on a YoY basis from $997000.0 in Q1 2025, and up 29.31% quarter-over-quarter from $2.8 million in Q4 2025.

Neurogene (NGNE) Prepaid Assets (2013 - 2026) Analysis & Trends

Neurogene has reported Prepaid Assets for 10 years, with the latest figure at $3.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Prepaid Assets rose 257.57% year-over-year to $3.6 million; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (up 257.57% YoY), and the FY2025 full-year result was $2.8 million, down 21.63% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $3.6 million, up from $2.8 million in the prior quarter.
  • The five-year high for Prepaid Assets was $5.1 million in Q3 2025, with the low at $630000.0 in Q4 2022.
  • Historically, Prepaid Assets has averaged $2.2 million across 5 years, with a median of $2.0 million in 2022.
  • Annual changes were most pronounced in 2022 — Prepaid Assets sank 58.61% — and 2023, when it surged 406.51%.
  • Neurogene's Prepaid Assets stood at $630000.0 in 2022, then surged by 406.51% to $3.2 million in 2023, then advanced by 10.25% to $3.5 million in 2024, then decreased by 21.63% to $2.8 million in 2025, then grew by 29.31% to $3.6 million in 2026.
  • The last three Prepaid Assets figures came in at $3.6 million (Q1 2026), $2.8 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Neurogene 216.17 Mn 216.17 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.57 Mn
Dec 31, 2025 2.76 Mn
Sep 30, 2025 5.11 Mn
Jun 30, 2025 970,000.00
Mar 31, 2025 997,000.00
Dec 31, 2024 3.52 Mn
Sep 30, 2024 1.60 Mn
Jun 30, 2024 1.53 Mn
Mar 31, 2024 1.25 Mn
Dec 31, 2023 3.19 Mn
Sep 30, 2023 1.39 Mn
Jun 30, 2023 1.72 Mn
Mar 31, 2023 2.20 Mn
Dec 31, 2022 630,000.00
Sep 30, 2022 1.98 Mn
Jun 30, 2022 2.03 Mn
Mar 31, 2022 2.31 Mn
Dec 31, 2021 1.52 Mn
Sep 30, 2021 1.57 Mn
Jun 30, 2021 3.26 Mn